BiPER Therapeutics

Strasbourg, France

BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.

$1.2M raised

Dec 2025

Seed

Biotechnology Pharmaceutical Therapeutics

Top Investors

BpifranceMedin Fund Management CoWiSEEDRégion Grand Est

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BiPER Therapeutics

How much funding has BiPER Therapeutics raised?

BiPER Therapeutics has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are BiPER Therapeutics's investors?

BiPER Therapeutics's investors include Bpifrance, Medin Fund Management Co, WiSEED, Région Grand Est.

Where is BiPER Therapeutics headquartered?

BiPER Therapeutics is headquartered in Strasbourg, France.

What does BiPER Therapeutics do?

BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.

What stage is BiPER Therapeutics at?

BiPER Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 2, 2025.

MLA

"BiPER Therapeutics — Funding & Investors." VCBacked, December 2, 2025, https://www.vcbacked.co/company/biper-therapeutics. Accessed June 7, 2026.

APA

VCBacked. (2025). BiPER Therapeutics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/biper-therapeutics

Wikipedia (cite web)

{{cite web |title=BiPER Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/biper-therapeutics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 2, 2025.

Similar Companies in Biotechnology